We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.35%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.33%
2 Technology 14.8%
3 Healthcare 13.84%
4 Industrials 13.25%
5 Energy 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.97T
$103M 2.29%
4,422,292
+73,528
+2% +$1.56M
XOM icon
2
ExxonMobil
XOM
$650B
$99.7M 2.22%
989,928
-42,500
-4% -$4.29M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.11T
$77.1M 1.72%
2,666,762
-147,668
-5% -$4.01M
JNJ icon
4
Johnson & Johnson
JNJ
$640B
$73.4M 1.63%
702,029
+178,100
+34% +$18M
MSFT icon
5
Microsoft
MSFT
$2.9T
$66.8M 1.49%
1,601,879
-245,000
-13% -$9.92M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$65.4M 1.46%
516,867
+3,800
+0.7% +$481K
SLB icon
7
SLB Ltd
SLB
$72.7B
$62.1M 1.38%
526,814
-2,900
-0.5% -$299K
ORCL icon
8
Oracle
ORCL
$339B
$58.5M 1.3%
1,443,943
-45,500
-3% -$1.87M
PFE icon
9
Pfizer
PFE
$143B
$57.2M 1.27%
2,032,139
+81,052
+4% +$2.31M
UNP icon
10
Union Pacific
UNP
$174B
$56.6M 1.26%
567,560
-5,200
-0.9% -$504K
BAC icon
11
Bank of America
BAC
$429B
$55.7M 1.24%
3,624,492
-9,100
-0.3% -$141K
WFC icon
12
Wells Fargo
WFC
$254B
$52.5M 1.17%
998,436
+15,300
+2% +$769K
COP icon
13
ConocoPhillips
COP
$144B
$50M 1.11%
583,394
+223,279
+62% +$17.4M
JPM icon
14
JPMorgan Chase
JPM
$916B
$49.6M 1.1%
860,770
-131,695
-13% -$7.4M
QCOM icon
15
Qualcomm
QCOM
$164B
$48.9M 1.09%
617,518
– –
T icon
16
AT&T
T
$164B
$45.5M 1.01%
1,704,409
+7,167
+0.4% +$192K
CVS icon
17
CVS Health
CVS
$135B
$44.6M 0.99%
591,412
-300
-0.1% -$22.7K
CMCSA icon
18
Comcast
CMCSA
$87.3B
$42.3M 0.94%
1,577,532
+11,400
+0.7% +$293K
OXY icon
19
Occidental Petroleum
OXY
$55.7B
$41M 0.91%
417,377
– –
MRK icon
20
Merck
MRK
$322B
$40.5M 0.9%
734,255
+493,398
+205% +$26.9M
CVX icon
21
Chevron
CVX
$382B
$38.7M 0.86%
296,521
-40,100
-12% -$4.99M
VZ icon
22
Verizon
VZ
$197B
$37.6M 0.84%
769,331
-403,606
-34% -$19.6M
GILD icon
23
Gilead Sciences
GILD
$165B
$37.6M 0.84%
453,873
+257,262
+131% +$20M
HD icon
24
Home Depot
HD
$337B
$37.6M 0.84%
464,500
– –
MDT icon
25
Medtronic
MDT
$112B
$37.5M 0.83%
587,492
– –
1
2 3 4 5

Similar funds

BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
SCM
SunTx Capital Management Dallas, Texas $21.3M AUM 12.38% 1-Year Est. Return
CFG
Claremont Financial Group Claremont, California $23.4M AUM
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
YEPV
Yorktown Energy Partners V New York $5.41M AUM
WIA
Wealthstreet Investment Advisors Dallas, Texas $3.71M AUM 13.1% 1-Year Est. Return
LSM
Light Sky Macro New York $1.34M AUM
FFIM
Founders Fund IV Management San Francisco, California $1.21M AUM

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.